Opioid Maker Charged With Fraud In Marketing Drug As Less Prone To Abuse

April 12, 2019

Federal prosecutors charged British drug maker Indivior with felony fraud and conspiracy for its marketing of opioid products including Suboxone. The company allegedly created a “nationwide scheme” in the U.S. designed to convince doctors and government insurance providers that Indivior’s patented opioid medications are safer and less prone to abuse than cheaper generic alternatives. Read More >>

BHAP Logo

A national trade membership association that provides education and advocacy for behavioral healthcare providers and related entities.

We are the leading and unifying voice of addiction-focused treatment programs.

Login

Join Now


Contact Us


Hours
Monday - Friday
8:30 am - 4:30 pm Pacific
(closed major holidays)